50090-7726 NDC - ATORVASTATIN CALCIUM

Drug Information

Product NDC: 50090-7726
Proprietary Name: atorvastatin calcium
Non Proprietary Name: atorvastatin calcium
Active Ingredient(s): 40 mg/1 ATORVASTATIN CALCIUM TRIHYDRATE
Administration Route(s): ORAL
Dosage Form(s): TABLET
Pharmacy Class(es): HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

Labeler Information

Field Name	Field Value
Labeler Name:	A-S Medication Solutions
Product Type:	HUMAN PRESCRIPTION DRUG
FDA Application Number:	ANDA206536
Marketing Category:	ANDA
Start Marketing Date:	6/12/2024

Package Information

No.	Package Code	Package Description	Billing Unit
1	50090-7726-0	30 TABLET in 1 BOTTLE (50090-7726-0)	EA
2	50090-7726-1	90 TABLET in 1 BOTTLE (50090-7726-1)	EA
3	50090-7726-2	100 TABLET in 1 BOTTLE (50090-7726-2)	EA

NDC Record

Field Name	Field Value	Definition
PRODUCT NDC	50090-7726	The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAME	HUMAN PRESCRIPTION DRUG	Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAME	atorvastatin calcium	The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAME	atorvastatin calcium	The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAME	TABLET	The translation of the dosage form Code submitted by the firm.
ROUTE NAME	ORAL	The translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE	6/12/2024	This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAME	ANDA	The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
APPLICATION NUMBER	ANDA206536	A suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard.
LABELER NAME	A-S Medication Solutions	This is the date that the labeler indicates was the start of its marketing of the drug product.
SUBSTANCE NAME	ATORVASTATIN CALCIUM TRIHYDRATE	This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
ACTIVE NUMERATOR STRENGTH	40
ACTIVE INGRED UNIT	mg/1
PHARM CLASSES	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 1/2/2026

Previous Code

Next Code